DOI:
10.1055/s-00000094
Zeitschrift für Gastroenterologie
LinksClose Window
References
Portenoy RK et al.
Subcutaneous methylnaltrexone for the treatment of opioid-induced constipation in patients with advanced illness: a double-blind, randomized, parallel group, dose-ranging study.
J Pain Symptom Manage 2008;
35 (05) 458-468
We do not assume any responsibility for the contents of the web pages of other providers.